Suppr超能文献

不植骨的骨凿上颌窦底提升术:一项10年的前瞻性研究

Osteotome Sinus Floor Elevation without Grafting: A 10-Year Prospective Study.

作者信息

Nedir Rabah, Nurdin Nathalie, Vazquez Lydia, Abi Najm Semaan, Bischof Mark

机构信息

Swiss Dental Clinics Group, Ardentis Clinique Dentaire, Vevey, Switzerland.

Department of Orofacial Rehabilitation, Oral and Maxillofacial Radiology, University Clinics of Dental Medicine, University of Geneva, Geneva, Switzerland.

出版信息

Clin Implant Dent Relat Res. 2016 Jun;18(3):609-17. doi: 10.1111/cid.12331. Epub 2015 Mar 18.

Abstract

BACKGROUND

Little is known about the long-term outcome of implants placed in the atrophic maxilla using osteotome sinus floor elevation (OSFE) without grafting.

PURPOSE

The study aims to evaluate the long-term efficiency of the procedure and stability of the peri-implant bone formed following implant placement without grafting into resorbed posterior maxilla.

MATERIALS AND METHODS

Twenty-five implants (≤10 mm in length) were placed in 17 patients using OSFE without grafting. The mean residual bone height was 5.4 ± 2.3 mm. Bone levels were evaluated at 1, 3, 5, and 10 years using periapical radiographs.

RESULTS

Fifteen patients (23 implants) participated in the 10-year examination. All implants fulfilled the survival criteria. Following surgery, the implant sites gained endo-sinus bone (mean: 3.0 ± 1.4 mm). The mean crestal bone loss (CBL) was limited to 1.0 ± 0.9 mm. The difference in mean endo-sinus bone gain and CBL was statistically significant between 1 and 10 years, but not between 3 and 5, 3 and 10, and 5 and 10 years.

CONCLUSIONS

At 10 years, the implant survival rate was 100%. Endo-sinus bone was mainly gained during the first year. This study demonstrates the long-term predictability of OSFE without grafting and simultaneous implant placement.

摘要

背景

对于使用骨凿上颌窦底提升术(OSFE)且不植骨的情况下植入萎缩性上颌骨的种植体的长期预后知之甚少。

目的

本研究旨在评估该手术的长期效果以及在不植骨的情况下植入上颌后牙区吸收骨后种植体周围形成的骨的稳定性。

材料与方法

使用OSFE且不植骨的方法为17例患者植入了25颗种植体(长度≤10毫米)。平均剩余骨高度为5.4±2.3毫米。使用根尖片在1年、3年、5年和10年时评估骨水平。

结果

15例患者(23颗种植体)参与了10年的检查。所有种植体均符合生存标准。术后,种植体部位获得了窦内骨(平均:3.0±1.4毫米)。平均嵴顶骨吸收(CBL)限制在1.0±0.9毫米。1年和10年之间窦内骨平均增加量与CBL的差异具有统计学意义,但3年和5年、3年和10年以及5年和10年之间没有差异。

结论

10年后,种植体存活率为100%。窦内骨主要在第一年获得。本研究证明了不植骨同时植入种植体的OSFE的长期可预测性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验